跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
替米沙坦氢氯噻嗪片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Telmisartan and Hydrochlorothiazide Tablets
Approved
化学药品
Telmisartan and Hydrochlorothiazide Tablets
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
Jan 24, 2024
Approval ID
8XRlIOCrwit
Company
Boehringer Ingelheim International GmbH
Type
化学药品
Approval Details
Approval Id
8XRlIOCrwit
Approval Number
国药准字HJ20171207
Generic Name
替米沙坦氢氯噻嗪片
Generic Name En
Telmisartan and Hydrochlorothiazide Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含替米沙坦80mg，氢氯噻嗪12.5mg
Reg Date
2024-01-24
Expired Date
2029-01-23
Company Name
Boehringer Ingelheim International GmbH
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 24, 2024
Approval ID
8XRlIOCrwit
Type
化学药品
Back to NMPA Approvals
